SARS-CoV-2

From transparent masks to antimicrobial coatings, newer face masks in development will include advanced design features and materials.

Regular disinfection can help to limit the spread of viral infections such as COVID-19, but only if carried out appropriately, write Xian Jun Loh and colleagues.

Antiviral strategies against COVID-19 broadly fall into two groups: those that target the virus and those that target the host factors that are essential for virus replication.

COVID-19 has catalyzed radical changes in our relationship with single-use plastic, according to a study by an international team of researchers.

In a display of scientific willpower, A*STAR researchers developed and deployed the COVID-19 diagnostic Fortitude Kit within weeks of the virus reaching Singapore’s shores.

Tipped off by artificial intelligence, a research team is testing whether a rheumatoid arthritis drug could be repurposed as a COVID-19 treatment.

Stem cell experts recognize the potential of exosomes for treating COVID-19 pneumonia, but caution that rigorous clinical testing is needed.

An international genetics consortium seeks to unravel the mystery of why COVID-19 infection is silent in some cases and lethal in others.

Understanding how closely related coronaviruses circulate seasonally could impact the timing of vaccination against SARS-CoV-2.

Two linear peptides identified by A*STAR researchers on the SARS-CoV-2 spike protein may improve the specificity of serological assays and show potential as vaccine candidates.

Lisa F. P. Ng, a leading infectious disease expert on infection and immunity, shares how her team’s prior experience has helped them quickly understand the nature of SARS-CoV-2, the virus that causes COVID-19.